Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBLG NASDAQ:NVNO NASDAQ:QNRX NASDAQ:TNON On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBLGBone Biologics$1.23-1.6%$1.27$1.05▼$6.75$2.24M0.9314,510 shs16,875 shsNVNOenVVeno Medical$10.21-5.0%$10.86$8.67▼$196.70$7.18M1.110,921 shs3,259 shsQNRXQuoin Pharmaceuticals$4.49+4.7%$5.79$4.11▼$41.80$8.62M1.5630,541 shs20,178 shsTNONTenon Medical$0.60-4.9%$0.74$0.58▼$2.48$7.35M1.2686,823 shs52,487 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBLGBone Biologics+1.45%-3.52%-4.62%-1.64%-74.66%NVNOenVVeno Medical+0.37%-3.28%+3.56%-6.20%-91.65%QNRXQuoin Pharmaceuticals-3.16%-13.16%-32.01%-50.52%-52.33%TNONTenon Medical+0.79%-9.03%-14.30%-16.90%-39.52%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBLGBone Biologics$1.23-1.6%$1.27$1.05▼$6.75$2.24M0.9314,510 shs16,875 shsNVNOenVVeno Medical$10.21-5.0%$10.86$8.67▼$196.70$7.18M1.110,921 shs3,259 shsQNRXQuoin Pharmaceuticals$4.49+4.7%$5.79$4.11▼$41.80$8.62M1.5630,541 shs20,178 shsTNONTenon Medical$0.60-4.9%$0.74$0.58▼$2.48$7.35M1.2686,823 shs52,487 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBLGBone Biologics+1.45%-3.52%-4.62%-1.64%-74.66%NVNOenVVeno Medical+0.37%-3.28%+3.56%-6.20%-91.65%QNRXQuoin Pharmaceuticals-3.16%-13.16%-32.01%-50.52%-52.33%TNONTenon Medical+0.79%-9.03%-14.30%-16.90%-39.52%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBLGBone Biologics 1.00SellN/AN/ANVNOenVVeno Medical 1.50ReduceN/AN/AQNRXQuoin Pharmaceuticals 1.00SellN/AN/ATNONTenon Medical 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownLatest BBLG, QNRX, TNON, and NVNO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2026TNONTenon Medical Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy4/27/2026BBLGBone Biologics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)4/22/2026QNRXQuoin Pharmaceuticals Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/20/2026TNONTenon Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026BBLGBone Biologics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026NVNOenVVeno Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBLGBone BiologicsN/AN/AN/AN/A$3.00 per shareN/ANVNOenVVeno MedicalN/AN/AN/AN/A$41.38 per shareN/AQNRXQuoin PharmaceuticalsN/AN/AN/AN/A$15.64 per shareN/ATNONTenon Medical$3.94M1.77N/AN/A$0.18 per share3.36Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBLGBone Biologics-$3.11M-$2.27N/AN/AN/AN/A-50.47%-47.40%8/13/2026 (Estimated)NVNOenVVeno Medical-$19.47M-$25.54N/AN/AN/AN/A-66.39%-60.42%7/30/2026 (Estimated)QNRXQuoin Pharmaceuticals-$15.81M-$29.56N/AN/AN/AN/A-489.85%-221.29%8/6/2026 (Estimated)TNONTenon Medical-$12.56M-$1.29N/AN/AN/A-270.09%-907.60%-110.17%8/12/2026 (Estimated)Latest BBLG, QNRX, TNON, and NVNO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026BBLGBone Biologics-$0.43-$0.43N/A-$0.43N/AN/A5/12/2026Q1 2026TNONTenon Medical-$0.3050-$0.31-$0.0050-$0.31$1.30 million$1.38 million5/7/2026Q1 2026NVNOenVVeno Medical-$8.40-$5.89+$2.51-$5.89$0.50 millionN/A5/7/2026Q1 2026QNRXQuoin Pharmaceuticals-$2.17-$1.77+$0.40-$1.77N/AN/A3/27/2026Q4 2025QNRXQuoin Pharmaceuticals-$6.42-$14.80-$8.38-$1.74N/AN/A3/19/2026Q4 2025TNONTenon Medical-$0.36-$0.22+$0.14-$0.22$1.38 million$1.48 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBBLGBone BiologicsN/AN/AN/AN/AN/ANVNOenVVeno MedicalN/AN/AN/AN/AN/AQNRXQuoin PharmaceuticalsN/AN/AN/AN/AN/ATNONTenon MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBLGBone BiologicsN/A16.1116.11NVNOenVVeno MedicalN/A11.8911.89QNRXQuoin PharmaceuticalsN/A2.872.87TNONTenon MedicalN/A1.030.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBLGBone Biologics34.30%NVNOenVVeno Medical34.71%QNRXQuoin Pharmaceuticals8.63%TNONTenon Medical22.74%Insider OwnershipCompanyInsider OwnershipBBLGBone Biologics6.10%NVNOenVVeno Medical15.00%QNRXQuoin Pharmaceuticals13.46%TNONTenon Medical0.33%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBLGBone Biologics21.80 million1.69 millionNot OptionableNVNOenVVeno Medical30670,000568,000OptionableQNRXQuoin Pharmaceuticals42.01 million1.74 millionNot OptionableTNONTenon Medical811.57 million11.54 millionNot OptionableBBLG, QNRX, TNON, and NVNO HeadlinesRecent News About These CompaniesTenon Medical (NASDAQ:TNON) Trading Down 6.9% - Time to Sell?June 3 at 6:29 AM | americanbankingnews.comTenon Medical Faces Nasdaq Deficiency, Compliance Plan DueMay 22, 2026 | tipranks.comTenon Medical CEO Foster buys $25k in TNON stock and warrantsMay 16, 2026 | investing.comTenon Medical, Inc. (NASDAQ:TNON) Q1 2026 Earnings Call TranscriptMay 13, 2026 | insidermonkey.comTenon Medical Earnings Call Highlights Rapid Growth PivotMay 13, 2026 | tipranks.comTenon(R) Medical Reports First Quarter 2026 Financial ResultsMay 12, 2026 | accessnewswire.comATenon Medical, Inc. Sets Date for First Quarter 2026 EarningsMay 1, 2026 | accessnewswire.comATenon Medical (TNON) price target increased by 10.00% to 2.80April 9, 2026 | msn.comTenon Medical Earnings Call Highlights Growth And RiskMarch 20, 2026 | tipranks.comTenon Medical, Inc. (NASDAQ:TNON) Q4 2025 Earnings Call TranscriptMarch 20, 2026 | insidermonkey.comTenon Medical Inc (TNON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...March 19, 2026 | uk.finance.yahoo.comTenon Medical (TNON) Q4 2025 Earnings TranscriptMarch 19, 2026 | fool.comTenon Medical, Inc.: Tenon Medical Reports Fourth Quarter and Full Year 2025 Financial ResultsMarch 19, 2026 | finanznachrichten.deTenon Medical outlines growth acceleration plans following 92% Q4 revenue jump and expanded SI-Joint Fusion portfolioMarch 19, 2026 | seekingalpha.comTenon Medical, Inc. (TNON) Q4 2025 Earnings Call TranscriptMarch 19, 2026 | seekingalpha.comTenon(R) Medical Reports Fourth Quarter and Full Year 2025 Financial ResultsMarch 19, 2026 | accessnewswire.comATenon Medical, Inc.: Tenon Medical Announces Closing of Private Placement of Senior Convertible Notes Offering for Gross Proceeds of $ 4.3 MillionMarch 13, 2026 | finanznachrichten.deWallachBeth Capital Announces Closing of Tenon Medical, Inc Private Placement of Senior Original Issue Discount Convertible Notes Offering for Gross Proceeds of $4.3 MillionMarch 12, 2026 | prnewswire.comTenon Medical Announces Closing of Private Placement of Senior Convertible Notes Offering for Gross Proceeds of $ 4.3 MillionMarch 12, 2026 | accessnewswire.comATenon Medical Receives Nasdaq Minimum Bid Price Deficiency NoticeFebruary 27, 2026 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBBLG, QNRX, TNON, and NVNO Company DescriptionsBone Biologics NASDAQ:BBLG$1.23 -0.02 (-1.60%) Closing price 03:53 PM EasternExtended Trading$1.25 +0.02 (+1.22%) As of 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.enVVeno Medical NASDAQ:NVNO$10.21 -0.54 (-5.02%) Closing price 04:00 PM EasternExtended Trading$10.38 +0.17 (+1.67%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial. Quoin Pharmaceuticals NASDAQ:QNRX$4.49 +0.20 (+4.66%) Closing price 04:00 PM EasternExtended Trading$4.46 -0.03 (-0.56%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.Tenon Medical NASDAQ:TNON$0.60 -0.03 (-4.88%) Closing price 04:00 PM EasternExtended Trading$0.62 +0.02 (+3.15%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below Five Below Down 12% Post Earnings—Is the Selloff Overdone? Buy the Dip? Broadcom's AI Moat Is Wider Than Ever The Market Has Ollie’s Bargain Outlet Completely Wrong Broadcom's Whiplash: Shares Tank After Pre-Earnings Surge Navitas: NVIDIA’s AI Power Broker? Macy's Delivers Strong Q1, Raises Outlook, but Wall Street Remains Cautious NVIDIA's New Power Play: Why Fluence Is Surging Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
